Cryptococcal meningitis is a fungal infection that mainly affects people with HIV and causes severe illness. In 2014 two women, Elube and Patricia, arrived at Kamuzu Central Hospital in Lilongwe with worsening headaches; both became unconscious and were later diagnosed with HIV and cryptococcal meningitis.
Clinicians used lumbar punctures to reduce pressure inside the skull, which often eased severe headaches but did not always prevent long-term damage. Patricia lost her sight more than ten years ago and has not recovered it. Doctors explain that the fungus is common in the environment and can lie dormant until a weak immune system allows it to spread to the central nervous system.
WHO guidance changed from a week of amphotericin B deoxycholate plus oral flucytosine and fluconazole to a 2022 recommendation for a single high dose of liposomal amphotericin B with flucytosine and fluconazole. Because taking flucytosine four times daily is difficult, the Drugs for Neglected Diseases initiative is running a Phase II trial at Kamuzu using a sustained‑release pellet made by Viatris to reduce doses; the trial is halfway enrolled and results are expected in 2027. Clinicians say late presentation, weak diagnostics and low community awareness keep mortality high, and they call for more testing and earlier care.
Difficult words
- cryptococcal — related to Cryptococcus fungus that can infect people
- meningitis — inflammation of the membranes around the brain
- lumbar puncture — procedure to remove fluid from the spinal canallumbar punctures
- dormant — inactive but able to become active later
- immune system — body system that fights infection and disease
- flucytosine — an antifungal medicine used with other drugs
- mortality — the number of deaths in a group
- diagnostics — tests and methods to find a disease
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- What could be done in a community to encourage people to seek care earlier for severe headaches?
- How might easier or faster diagnostics change outcomes for patients like Elube and Patricia?
- Have you or someone you know found it difficult to take a medicine several times a day? What helped or would help?
Related articles
Most young users still smoke nicotine, tobacco or cannabis
A 2022–23 study of people aged 12–34 found most young Americans who use nicotine, tobacco or cannabis still smoke one or more combustible products. The research groups users by their usual product patterns and urges targeted prevention.
Lower chemotherapy dose helps people 80+ with lymphoma
A study found that people aged 80 and older with a common lymphoma often do better with a lower chemotherapy dose. Researchers used data from community cancer clinics and say the smaller dose kept effectiveness while reducing side effects.
New oral drug approved for sleeping sickness
European regulators approved Acoziborole, a single-dose oral treatment for sleeping sickness after successful trials in the DRC and Guinea. Sanofi will donate doses to WHO, but national approvals and vector control are still needed to reach elimination goals.